CAS No. |
2135-17-3 |
中文名称 |
(6S,8S,10S,11S,13S,14S,16R,17R)-6,9-二氟-11,17-二羟基-17-(2-羟基乙酰基)-10,13,16-三甲基-6,7,8,9,10,11,12,13,14,15,16,17-十二氢-3H-环戊烷并[a]菲-3-酮 |
英文名称 |
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
别名 |
C22H28F2O5 | DB00663 | EINECS 218-370-9 | Flumethasone [USAN] | Cortexilar | Flumethasonum | A855571 | Flumetasone | NSC54702 | NSC-54702 | Pregna-1,4-diene-3,20-dione,6,9-difluoro-11,17,21-trihydroxy-16-methyl-, (6a,11b,16a)- | SMR000058690 | Flumetasonu |
标准英文名 |
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
MDL No. |
MFCD00056464 |
分子式 |
C22H28F2O5 |
分子量 |
410.19
|
精确分子量 |
410.19
|
SMILES |
F[C@@]12[C@](C[C@@H](C([C@@]2(C=C3)C)=CC3=O)F)([H])[C@@]4([H])[C@](C[C@@H]1O)([C@](O)([C@@H](C4)C)C(CO)=O)C |
标准SMILES |
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO |
用途 |
Flumethasone is a synthetic difluorinated glucocorticoid used topically as a medium-potency corticosteroid for the treatment of non-infectious inflammatory dermatoses, particularly those associated with hyperkeratosis, such as seborrheic dermatitis, contact dermatitis, atopic dermatitis, localized neurodermatitis, plaque psoriasis, lichen planus, and palmoplantar keratoderma; it is commonly formulated as a combination ointment with salicylic acid to enhance penetration into the stratum corneum and potentiate its anti-inflammatory, anti-allergic, vasoconstrictive, and anti-proliferative effects; it is also used in veterinary medicine for the treatment of severe acute bronchopneumonia and ketosis in calves, where it improves clinical recovery, reduces mortality, increases plasma glucose levels, and decreases serum β-hydroxybutyrate and urinary acetoacetate concentrations. |
InChIKey |
WXURHACBFYSXBI-GQKYHHCASA-N |